PPARγ in Neuroblastoma
Joint Authors
Serio, Mario
Cellai, Ilaria
Baglioni, Silvana
Luciani, Paola
Benvenuti, Susanna
Peri, Alessandro
Source
Issue
Vol. 2008, Issue 2008 (31 Dec. 2008), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2008-05-19
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Neuroblastoma (NB) is the most common extracranial tumor in children and accounts for around 15% of all paediatric oncology deaths.
The treatment of NB includes surgery, chemotherapy, and radiotherapy.
Unfortunately, most children with NB present with advanced disease, and more than 60% of patients with high-risk features will have a poor prognosis despite intensive therapy.
Agonists of the nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) have been shown to have pleiotropic effects, including antineoplastic effects.
The studies that addressed the role and the possible mechanism(s) of action of PPARγ in NB cells are reviewed.
American Psychological Association (APA)
Peri, Alessandro& Cellai, Ilaria& Benvenuti, Susanna& Luciani, Paola& Baglioni, Silvana& Serio, Mario. 2008. PPARγ in Neuroblastoma. PPAR Research،Vol. 2008, no. 2008, pp.1-7.
https://search.emarefa.net/detail/BIM-988247
Modern Language Association (MLA)
Peri, Alessandro…[et al.]. PPARγ in Neuroblastoma. PPAR Research No. 2008 (2008), pp.1-7.
https://search.emarefa.net/detail/BIM-988247
American Medical Association (AMA)
Peri, Alessandro& Cellai, Ilaria& Benvenuti, Susanna& Luciani, Paola& Baglioni, Silvana& Serio, Mario. PPARγ in Neuroblastoma. PPAR Research. 2008. Vol. 2008, no. 2008, pp.1-7.
https://search.emarefa.net/detail/BIM-988247
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-988247
